Advertisement

Topics

Navidea Management to Host Moderated Q&A Webcast to Provide Corporate Update

17:47 EDT 12 Jul 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Webcast will also focus on Proxy Updates Navidea Biopharmaceuticals (NYSE American: NAVB) (Navidea or The Company), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced ...

Other Sources for this Article

Navidea Biopharmaceuticals
Jed Latkin, 614-551-3416
CFO/COO
jlatkin@navidea.com
or
Edison Advisors
Joe Green, 646-653-7030
jgreen@edisongroup.com

NEXT ARTICLE

More From BioPortfolio on "Navidea Management to Host Moderated Q&A Webcast to Provide Corporate Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...